A molecular comparison of microbial communities in bronchiectasis and cystic fibrosis

European Respiratory Journal

Volumn 41, Issue 4, 2013, Pages 991-993

  Duff, Rachael M ^a   Simmonds, Nicholas J ^b   Davies, Jane C ^a,b   Wilson, Robert ^b   Alton, Eric W ^a,b   Pantelidis, Panagiotis ^a   Cox, Michael J ^a   Cookson, William O C M ^a   Bilton, Diana ^b   Moffatt, Miriam F ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL DNA; COLISTIN; RNA 16S; TOBRAMYCIN;

ACHROMOBACTER; ADULT; AGED; BRONCHIECTASIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENE SEQUENCE; HAEMOPHILUS; HUMAN; LETTER; LUNG MYCOSIS; MALE; MICROBIAL COMMUNITY; MOLECULAR BIOLOGY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVOTELLA; PRIORITY JOURNAL; PROTEOBACTERIA; PSEUDOMONAS AERUGINOSA; RRNA GENE; SPUTUM ANALYSIS; UNINDEXED SEQUENCE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BRONCHIECTASIS; CYSTIC FIBROSIS; HUMANS; INFLAMMATION; METAGENOME; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; RNA, RIBOSOMAL, 16S; SPUTUM;

EID: 84875825853     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00052712     Document Type: Letter

References (11)

1. Staley JT, Konopka A. Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats. Annu Rev Microbiol 1985; 39: 321-346.
2. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature 2007; 449: 804-810.
3. Rogers GB, Carroll MP, Serisier DJ, et al. Bacterial activity in cystic fibrosis lung infections. Respir Res 2005; 6: 49.
4. Cox MJ, Allgaier M, Taylor B, et al. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One 2010; 5: e11044.
5. Saiman L, Siegel J. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol 2003; 24: S6-S52.
6. Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS One 2010; 5: e8578.
7. Cole JR, Wang Q, Cardenas E, et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 2009; 37: D141-D145.
8. Waine DJ, Honeybourne D, Smith EG, et al. Cross-sectional and longitudinal multilocus sequence typing of Pseudomonas aeruginosa in cystic fibrosis sputum samples. J Clin Microbiol 2009; 47: 3444-3448.
9. King PT. The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis 2009; 4: 411-419.
10. Rogers GB, Daniels TW, Tuck A, et al. Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches. BMC Pulm Med 2009; 9: 14.
11. Maughan H, Cunningham KS, Wang PW, et al. Pulmonary bacterial communities in surgically resected noncystic fibrosis bronchiectasis lungs are similar to those in cystic fibrosis. Pulm Med 2012; 2012: 746358.